Importance of experiments in poliovirus-susceptible transgenic mice for evaluating current potency tests of inactivated polio vaccine (IPV).
Taffs
R
R
FDA, Rockville, MD, USA.
Dragunsky
E
E
Nomura
T
T
Hioki
K
K
Levenbook
I
I
Fitzgerald
E
E
D000826:Animal Testing Alternatives / Q000379:methods*; D000818:Animals; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D011051:Poliomyelitis / Q000276:immunology / Q000517:prevention & control; D011054:Poliovirus Vaccine, Inactivated / Q000032:analysis / Q000494:pharmacology*; D011991:Receptors, Virus / Q000235:genetics; D015164:Vaccines, Inactivated / Q000032:analysis / Q000494:pharmacology
D011054:Poliovirus Vaccine, Inactivated; D011991:Receptors, Virus; D015164:Vaccines, Inactivated